Cancer Clinical Investigation

Search results

• Researcher at Department of Radiation Oncology Describes Research in Head and Neck Cancer (Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy)

  Daniel Dickstein & Richard Bakst

  7/03/23

  1 item of Media coverage

  Press/Media

• Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in …

  Oren Becher

  7/03/23

  1 item of Media coverage

  Press/Media

• Study Results from Icahn School of Medicine at Mount Sinai Update Understanding of Radiation Oncology (The Rise of Open Access Journals in Radiation Oncology: Influence on Resident Research, 2015 to 2019)

  Anthony Nehlsen, Eric Lehrer, Stanislav Lazarev, Kunal Sindhu, Brianna Jones, Michael Buckstein, Andrew Smith & Kenneth Rosenzweig

  6/03/23

  1 item of Media coverage

  Press/Media

• Study Findings from Icahn School of Medicine at Mount Sinai Advance Knowledge in Radiation Oncology (Gender Differences in the Research Productivity of Radiation Oncology Resident Graduates in the United States: 2015 to 2019)

  Anthony Nehlsen, Eric Lehrer, Kunal Sindhu, Sheryl Green, Karyn Goodman, Brianna Jones & Kristin Hsieh

  6/03/23

  1 item of Media coverage

  Press/Media

• Researchers develop novel approach to enhance drug delivery for brain tumours in children

  Oren Becher

  6/03/23

  1 item of Media coverage

  Press/Media

• Researchers develop novel approach to enhance drug delivery for brain tumours in children

  Oren Becher

  6/03/23

  1 item of Media coverage

  Press/Media

• Scientists develop novel approach to enhance drug delivery for brain tumors in children

  Oren Becher

  2/03/23 → 3/03/23

  2 items of Media coverage

  Press/Media

• Nanoparticles Target Medulloblastoma Tumor to Improve Drug Therapy and Reduce Toxicity

  Oren Becher

  3/03/23

  1 item of Media coverage

  Press/Media

• News Improved Tumor Drug Delivery Across Blood–Brain Barrier Researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children.

  Oren Becher

  3/03/23

  2 items of Media coverage

  Press/Media

• Mount Sinai Health System: Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children

  Oren Becher

  2/03/23

  1 item of Media coverage

  Press/Media

• Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children

  Oren Becher

  2/03/23

  2 items of Media coverage

  Press/Media

• Risk-Adapted Approach for Muscle-Invasive Bladder Cancer Requires Further Refinement

  Matthew Galsky

  1/03/23

  1 item of Media coverage

  Press/Media

• Researchers from University of Colorado Provide Details of New Studies and Findings in the Area of Squamous Cell Carcinoma (Egfr High Copy Number Together With High Egfr Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy ...)

  Fred Hirsch & Fred Hirsch

  27/02/23

  1 item of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai in the Area of Personalized Medicine Reported (The Combiome Hypothesis: Selecting Optimal Treatment for Cancer Patients)

  Fred Hirsch & Fred Hirsch

  27/02/23

  1 item of Media coverage

  Press/Media

• Studies from Universitat de Barcelona in the Area of Hepatoblastomas Published (Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma)

  Josep Llovet, Daniela Sia & Miguel Torres-Martin

  24/02/23

  1 item of Media coverage

  Press/Media

• Research from Icahn School of Medicine at Mount Sinai Broadens Understanding of Liver Cancer (Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors)

  Umut Özbek & Celina Ang

  24/02/23

  1 item of Media coverage

  Press/Media

• Mascarenhas Summarizes Therapeutic Standards and Advances in Myelofibrosis Management

  John Mascarenhas

  23/02/23

  1 item of Media coverage

  Press/Media

• Adjuvant nivolumab as standard of care in resected bladder cancer

  Matthew Galsky

  22/02/23

  2 items of Media coverage

  Press/Media

• Immunotherapy can benefit high-risk bladder patients after surgery

  Matthew Galsky

  22/02/23

  1 item of Media coverage

  Press/Media

• Medical Bulletin 20/February/2023

  Matthew Galsky

  20/02/23

  1 item of Media coverage

  Press/Media

• Immunotherapy can benefit high-risk bladder patients after surgery: Research

  Matthew Galsky

  19/02/23

  9 items of Media coverage

  Press/Media

• Research: High-risk bladder patients can benefit from immunotherapy after surgery

  Matthew Galsky

  19/02/23

  1 item of Media coverage

  Press/Media

• Nivolumab shows continued survival benefit in high-risk MIUC

  Matthew Galsky

  18/02/23

  2 items of Media coverage

  Press/Media

• Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

  Matthew Galsky

  17/02/23 → 18/02/23

  3 items of Media coverage

  Press/Media

• Mount Sinai Health System: Immunotherapy After Surgery Provides Significant, Durable Benefit for High-Risk Bladder Patients

  Matthew Galsky

  17/02/23

  1 item of Media coverage

  Press/Media